Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents

Pediatric Infectious Disease Journal

Volumn 26, Issue 1, 2007, Pages 61-67

  Martin, Staci ^a,c,f   Elliott DeSorbo, Deborah K ^a,c   Wolters, Pamela L ^a,c   Toledo Tamula, Mary Anne ^a,c   Roby, Gregg ^a,b,d   Zeichner, Steve ^a,e   Wood, Lauren V ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Medical Illness Counseling Center   (United States)

^d National Institute of Allergy and Infectious Diseases   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f NONE   (United States)

Author keywords

Disease knowledge; HAART; Medication adherence; Pediatric HIV disease; Regimen complexity; Treatment responsibility

Indexed keywords

ANTIRETROVIRUS AGENT; ENFUVIRTIDE;

ADOLESCENT; ADULT; ARTICLE; CAREGIVER; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE MARKER; DRUG DOSE REGIMEN; DRUG MONITORING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; LONGITUDINAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PREDICTION; PRIORITY JOURNAL; RESPONSIBILITY; VIRUS LOAD;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAREGIVERS; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; PATIENT COMPLIANCE; PATIENTS;

EID: 33846032697     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000250625.80340.48     Document Type: Article

References (27)

1. Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA. 2005;293:2221-2231.
2. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522-1528.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
4. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JSG. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med 2003;139:810-816.
5. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type l. Pediatr Infect Dis J. 1999;18:682-689.
6. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-347.
7. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37:1112-1118.
8. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23:1035-1041.
9. Berrien VM, Salazar JC, Reynolds E, McKay K. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDs. 2004;18:355-363.
10. Nicholson O, Mellins C, Dolezal C, Brackis-Cott E, Abrams EJ. HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children. Patient Educ Couns. 2006;61:405-410.
11. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovir. 1998;18:117-125.
12. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12:387-398.
13. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-395.
14. Stone VE, Jordan J, Tolson J, Miller R, Pilon T. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy. J Acquir Immune Defic Syndr. 2004;36:808-816.
15. Riekert KA. Health beliefs and medication adherence among adolescents with chronic health conditions [Dissertation Abstract, Case Western Reserve University]. Dissertation Abstracts International: Section B: The Sciences and Engineering 2001;61:4426.
16. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol. 1990;15:477-492.
17. Parienti J, Verdon R, Bazin C, Bouvet E, Massari V, Larouze B. The Pills Identification Test: A tool to assess adherence to antiretroviral therapy. JAMA. 2001;285:412.
18. George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the Medication Regimen Complexity Index. Ann Pharmacother. 2004;38:1369-1376.
19. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28:124-131.
20. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-133.
21. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy. 2000;20:941-949.
22. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002;36:1532-1539.
23. Farley JJ, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003;33:211-218.
24. Dolezal C, Mellins C, Brackis-Cott E, Abrams EJ. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003;28:355-361.
25. HIV/AIDS Surveillance Report. Atlanta: Centers for Disease Control and Prevention; 2004.
26. New MJ, Lee SS, Elliott BM. Psychological adjustment in children and families living with HIV [Epub ahead of print]. J Pediatr Psychol. 2006.
27. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153.